When we restricted the analysis to AD brains from the Knight-ADRC and compared the APOE ε4 carriers (n = 44) to non-carriers (n = 40) we also observed a decreased relative neuronal proportion (β = − 0.06; p = 2.69 × 10−02; Table 4; Fig. 4d). This evidence concerns the gene APOE and Alzheimer disease.